Publikacja:
Estimating R&D Returns In Health Care Industry
Data
2018
Artykuł
| cris.legacyid | 4834 |
| cris.virtual.journalance | #PLACEHOLDER_PARENT_METADATA_VALUE# |
| cris.virtualsource.journalance | dc92c553-0411-4522-97d5-b7ef33169392 |
| dc.abstract.pl | Purpose: This paper provides an empirical evaluation of R&D returns for a series of global companies who lead in innovation within the health care industry. Methodology: The estimation procedure bases on two specifications: the parametric production function setting, and finite distributed lag model (FDL). Findings: Using the most recent data on R&D investment by health care equipment and services along pharmaceuticals and biotechnology companies, we confirm the positive albeit mitigated impact of R&D efforts on performance indicators (levels of sales). Moreover, we comment on the current phenomena observed in health care industry and offer a policy view for ongoing and future challenges in the sector. Added value: Since there is a dearth of recent empirical evidence on R&D returns in the broad health industry, this paper offers the evaluation of economic incentives for companies to invest in R&D. These incentives embrace the induced increase in sales and profits levels. The authors participate in a public debate concerning the optimal levels of R&D rewards required to sustain the innovation within the sector. |
| dc.contributor.affiliation | Kozminski University |
| dc.contributor.affiliation | Kozminski University |
| dc.contributor.author | Waldemar Karpa |
| dc.contributor.author | Jakub Nowakowski |
| dc.date.accessioned | 2025-07-25T16:01:12Z |
| dc.date.available | 2025-07-25T16:01:12Z |
| dc.date.issued | 2018 |
| dc.date.published | 2018 |
| dc.description.issue | 2 |
| dc.description.physical | 34-46 |
| dc.description.volume | 26 |
| dc.identifier.doi | 10.7206/jmba.ce.2450-7814.227 |
| dc.identifier.issn | 2658-0845 |
| dc.identifier.uri | https://repozytorium.kozminski.edu.pl/handle/item/1605 |
| dc.language | en |
| dc.relation.ispartof | Central European Management Journal |
| dc.relation.pages | 34-46 |
| dc.subject | innovation |
| dc.subject | industrial policy |
| dc.subject | health economics |
| dc.subject | health policy |
| dc.subject | R&D |
| dc.title | Estimating R&D Returns In Health Care Industry |
| dc.type | Article |
| dspace.entity.type | Publication |